2015;10(7): e0133904
As of 23 June 2025 , GPs can prescribe Mounjaro to adults in Cohort 1 , defined as: BMI 40 kg/m (or 37.5 kg/m for people of South Asian, Chinese, other Asian, Middle Eastern, Black African or Afro-Caribbean ethnicity) At least 4 of the following 5 obesity-related health conditions : Hypertension (high blood pressure) Dyslipidaemia (high cholesterol) Obstructive sleep apnoea Cardiovascular disease Type 2 diabetes mellitus Why is NHS access limited to Cohort 1
Six minutes a day is really all it takes, and many of the guests on the show subscribe
But when it was new, like the new anti-obesity medications, it was labeled weight loss surgery or cosmetic surgery, and was not being covered by Medicare or by most third-party payers, he says
Recently, they have surged in popularity again thanks to TikTok, skin cycling routines, and skin longevity conversations that frame copper peptides as a powerful anti-aging ingredient capable of repairing skin on a cellular level
Possible Side Effects and Considerations While Tirzepatide is generally well-tolerated, some users may experience: Nausea Mild digestive discomfort Fatigue These side effects usually fade as your body adjusts to the medication